The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Positron Emission Tomography With [18F]Fluoro–2–Deoxy–D–Glucose for Diagnosis and Staging of Bile Duct Cancer
Abstract
Malignant tumors with high glucose metabolic rates accumulate [18F]–fluorodeoxyglucose (FDG), a positron emitting tracer. The aim of this study was to evaluate FDG positron emission tomography (PET) for detection and staging of human cholangiocarcinoma (CC). Patients with adenocarcinoma of the biliary tree (n = 26), with benign lesions of the bile ducts (n = 8), and 20 control patients underwent FDG–PET (370 MBq [18F]–FDG, Siemens ECAT EXACT HR+). In a blinded fashion, 4 independent experts evaluated the PET scans visually and semiquantitatively using the standardized uptake value and a tumor/non–tumor ratio. All adenocarcinomas and benign lesions (sclerosing cholangitis, bile duct adenoma, Caroli's disease) were histologically proven and imaged by magnetic resonance imaging and endoscopic retrograde cholangioscopy. True–positive PET scans were obtained in 24 of 26 CC and false–negative scans in the other 2 (sensitivity 92.3%). The PET scan was true–negative in 18 of 20 controls and in all 8 benign biliary lesions (specificity 92.9%). Visual and semiquantitative evaluation using tumor/non–tumor ratios were equally accurate (accuracy 92.6%) whereas evaluation by standardized uptake value revealed lower accuracy (P < .05). Regional or hepatoduodenal lymph node metastases were detected with PET in only 2 of 15 cases whereas distant metastases (peritoneal carcinomatosis, pulmonary metastases) were diagnosed in 7 of 10 cases. In conclusion, PET is highly sensitive and specific for the detection and localization of CC. It can be helpful for diagnosis of distant metastases but is not suitable for detection of regional lymph node metastases. (Hepatology 2001;33:1029–1035.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Accelerated image reconstruction using ordered subsets of projection data
Hudson, H. M., & Larkin, R. S. (1994) · IEEE Transactions on Medical Imaging · doi:10.1109/42.363108 · Cited by 3,711
ROC Methodology in Radiologic Imaging
METZ, C. E. (1986) · Investigative Radiology · doi:10.1097/00004424-198609000-00009 · Cited by 1,642
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
de Groen, P. C., Gores, G. J., LaRusso, N. F., Gunderson, L. L., & Nagorney, D. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910283411807 · Cited by 955
Management Strategies in Resection for Hilar Cholangiocarcinoma
BISMUTH, H., NAKACHE, R., & DIAMOND, T. (1992) · Annals of Surgery · doi:10.1097/00000658-199201000-00005 · Cited by 807
Prospective investigation of positron emission tomography in lung nodules.
Lowe, V. J., Fletcher, J. W., Gobar, L., Lawson, M., Kirchner, P., Valk, P., Karis, J., Hubner, K., Delbeke, D., Heiberg, E. V., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1075 · Cited by 552
Strauss, L. G. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01367602 · Cited by 527
Vansteenkiste, J. F., Stroobants, S. G., Dupont, P. J., De Leyn, P. R., Verbeken, E. K., Deneffe, G. J., Mortelmans, L. A., & Demedts, M. G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3201 · Cited by 439
Evaluation of Benign vs Malignant Hepatic Lesions With Positron Emission Tomography
Delbeke, D. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.5.510 · Cited by 312
Surgical Treatment in Proximal Bile Duct Cancer: A Single-Center Experience
Pichlmayr, R., Weimann, A., Klempnauer, J., Oldhafer, K. J., Maschek, H., Tusch, G., & Ringe, B. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00007 · Cited by 309
A PET study of 18 FDG uptake in soft tissue masses
Lodge, M. A., Lucas, J. D., Marsden, P. K., Cronin, B. F., O'Doherty, M. J., & Smith, M. A. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050355 · Cited by 300
Photodynamic therapy of nonresectable cholangiocarcinoma
Ortner, M. E. J., Liebetruth, J., Schreiber, S., Hanft, M., Wruck, U., Fusco, V., Müller, J. M., Hörtnagl, H., & Lochs, H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70537-2 · Cited by 269
Folpe, A. L., Lyles, R. H., Sprouse, J. T., Conrad, E. U., & Eary, J. F. (2000) · PubMed · Cited by 257
Liver Resection for Hilar and Peripheral Cholangiocarcinomas: A Study of 62 Cases
Madariaga, J. R., Iwatsuki, S., Todo, S., Lee, R. G., Irish, W., & Starzl, T. E. (1998) · Annals of Surgery · doi:10.1097/00000658-199801000-00011 · Cited by 254
Schiepers, C., Penninckx, F., De Vadder, N., Merckx, E., Mortelmans, L., Bormans, G., Marchal, G., Filez, L., & Aerts, R. (1995) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/s0748-7983(95)97046-0 · Cited by 235
“Natural History” of Unresected Cholangiocarcinoma: Patient Outcome After Noncurative Intervention
Farley, D. R., Weaver, A. L., & Nagorney, D. M. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.5.425 · Cited by 232
Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Delbeke, D., Rose, D. M., Chapman, W. C., Pinson, C. W., Wright, J. K., Beauchamp, R. D., Shyr, Y., & Leach, S. D. (1999) · PubMed · Cited by 223
Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma
McMasters, K. M., Tuttle, T. M., Leach, S. D., Rich, T., Cleary, K. R., Evans, D. B., & Curley, S. A. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00203-1 · Cited by 220
Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography
Keiding, S., Hansen, S. B., Rasmussen, H. H., Gee, A., Kruse, A., Roelsgaard, K., Tage-Jensen, U., & Dahlerup, J. F. (1998) · Hepatology · doi:10.1002/hep.510280316 · Cited by 210
Berr, F., Wiedmann, M., Tannapfel, A., Halm, U., Kohlhaw, K. R., Schmidt, F., Wittekind, C., Hauss, J., & Mössner, J. (2000) · Hepatology · doi:10.1002/hep.510310205 · Cited by 199
Self-citationZimny, M., Bares, R., Fa�, J., Adam, G., Cremerius, U., Dohmen, B., Klever, P., Sabri, O., Schumpelick, V., & Buell, U. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00841409 · Cited by 198
Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
Reske, S. N., Grillenberger, K. G., Glatting, G., Port, M., Hildebrandt, M., Gansauge, F., & Beger, H. G. (1997) · PubMed · Cited by 197
Steinert, H. C., Böni, R. A. H., Buck, A., Böni, R., Berthold, T., Marinček, B., Burg, G., & von Schulthess, G. (1995) · Radiology · doi:10.1148/radiology.195.3.7753998 · Cited by 193
Diederichs, C. G., Staib, L., Vogel, J., Glasbrenner, B., Glatting, G., Brambs, H.-J., Beger, H. G., & Reske, S. N. (2000) · Pancreas · doi:10.1097/00006676-200003000-00001 · Cited by 167
Stollfuß, J., Glatting, G., Friess, H., Kocher, F., Berger, H. G., & Reske, S. N. (1995) · Radiology · doi:10.1148/radiology.195.2.7724750 · Cited by 149
Ichiya, Y., Kuwabara, Y., Otsuka, M., Tahara, T., Yoshikai, T., Fukumura, T., Jingu, K., & Masuda, K. (1991) · PubMed · Cited by 145
Minn, H. R. I., & Soini, I. (1989) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00702620 · Cited by 143
HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma.
Fulcher, A. S., & Turner, M. A. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.169.6.9393153 · Cited by 117
Monakhov, N. K., Neĭshtadt, E. L., Шавловский, М. М., Шварцман, А. Л., & Neifakh, S. A. (1978) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/61.1.27 · Cited by 117
Hoekstra, O. S., Ossenkoppele, G. J., Golding, R. P., van Lingen, A., Visser, G. W. M., Teule, G. J. J., & Huijgens, P. C. (1993) · PubMed · Cited by 108
Can the standardized uptake value characterize primary brain tumors on FDG-PET?
Hustinx, R., Smith, R. J., Bénard, F., Bhatnagar, A., & Alavi, A. A. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050487 · Cited by 98
Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis.
Widjaja, A., Mix, H., Wagner, S., Graz, K. F., Hoff, J. V. D., Petrich, T., Meier, P. N., & Manns, M. P. (1999) · PubMed · Cited by 14
Cited by
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Khan, S. A., Davidson, B. R., Goldin, R. D., Heaton, N., Karani, J., Pereira, S. P., Rosenberg, W. M. C., Tait, P., Taylor-Robinson, S. D., Thillainayagam, A. V., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301748 · Cited by 797
Clinical diagnosis and staging of cholangiocarcinoma
Blechacz, B., Komuta, M., Roskams, T., & Gores, G. J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.131 · Cited by 747
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document
Khan, S. A., Davidson, B. R., Goldin, R., Pereira, S. P., Rosenberg, W. M. C., Taylor-Robinson, S. D., Thillainayagam, A. V., Thomas, H. C., Thursz, M. R., & Wasan, H. (2002) · Gut · doi:10.1136/gut.51.suppl_6.vi1 · Cited by 648
Cholangiocarcinoma: Current Knowledge and New Developments
Blechacz, B. (2017) · Gut and Liver · doi:10.5009/gnl15568 · Cited by 485
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma
Anderson, C. D., Rice, M. H., Pinson, C. W., Chapman, W. C., Chari, R. S., & Delbeke, D. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2003.10.003 · Cited by 377
Metadata
- Authors
- Kluge, R., Schmidt, F., Caca, K., Barthel, H., Hesse, S., Georgi, P., Seese, A., Huster, D., & Berr, F.
- Venue
- Hepatology
- Published
- 2001-05
- Volume
- 33
- Issue
- 5
- Pages
- 1029-1035
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2094475323
- Cited by
- 265
- References
- 33
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.